Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes

GLIA

Volumn 33, Issue 4, 2001, Pages 314-323

  Bajenaru, Michaela Livia ^a   Donahoe, Jessica ^a   Corral, Teresa ^b   Reilly, Karlyne M ^c   Brophy, Sean ^a   Pellicer, Angel ^b   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Glioma; GTPase activating protein; Neurofibromin; p21 ras

Indexed keywords

NERVE PROTEIN; NEUROFIBROMIN; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL; ARTICLE; ASTROCYTE; ASTROCYTOMA; BRAIN TUMOR; CELL COUNT; CELL CULTURE; CELL DIVISION; CYTOLOGY; GENETICS; HETEROZYGOTE; MOUSE; MOUSE MUTANT; NEOCORTEX; PHYSIOLOGY;

ANIMALS; ASTROCYTES; ASTROCYTOMA; BRAIN NEOPLASMS; CELL COUNT; CELL DIVISION; CELLS, CULTURED; HETEROZYGOTE; MICE; MICE, KNOCKOUT; NEOCORTEX; NERVE TISSUE PROTEINS; NEUROFIBROMIN 1; PROTO-ONCOGENE PROTEINS P21(RAS); RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035075794     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-1136(20010315)33:4<314::AID-GLIA1030>3.0.CO;2-Q     Document Type: Article

References (40)

1. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins
2. Aberrant regulation of ras proteins in tumour cells from type 1 neurofibromatosis patients
3. Regulators and effectors of ras proteins
4. Loss of NF1 results in activation of the ras signaling pathway and leads to aberrant growth in haematopoietic cells
5. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues
6. Mouse models of tumor development in neurofibromatosis type 1
7. ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis
8. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
9. The murine gene p27-Kip1 is haploinsufficient for tumour suppression
10. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors
11. Proliferation of human malignant astrocytomas is dependent on ras activation
12. Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation
13. Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas
14. Precocious puberty in children with neurofibromatosis type 1
15. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein
16. Increased expression of the neurofibromatosis 1 (NF1) tumor suppressor gene protein, neurofibromin, in reactive astrocytes in vitro
17. Combined activation of ras and akt in neural progenitors induces glioblastoma multiforme
18. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo
19. Effects of an Rb mutation in the mouse
20. Tumor predisposition in mice heterozygous for a targeted mutation in NF1
21. Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: Reversion of some phenotypes by an inhibitor of farsenyl protein transferase
22. Loss of neurofibromin is associated with activation of ras/MAPK and PI3-K/akt signaling in a neurofibromatosis 1 astrocytoma
23. Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study
24. Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NF1 optic pathway glioma task force
25. Tumorigenesis and male sterility in transgenic mice expressing a MMTV/N-ras oncogene
26. NF1 inactivation cooperates with N-ras in in vivo lymphogenesis activating ERk by a mechanism independent of its Ras-GTPase accelerating activity
27. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21
28. Chromosome 17p deletions and p53 gene mutation associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis
29. Brainstem gliomas in patients with neurofibromatosis type 1: A distinct clinical entity
30. Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation
31. Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains
32. The management of brainstem gliomas in patients with neurofibromatosis 1
33. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
34. Multiple mechanisms of benign tumor formation in neurofibromatosis type 1
35. Transforming growth factor β-1 is a new form of tumor suppressor with true haploid insufficiency
36. Retention of wild-type p53 in tumors from p53 heterozygous mice: Reduction of p53 dosage can promote cancer formation
37. Mouse tumor model for neurofibromatosis type 1
38. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae
39. Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice